BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22699677)

  • 21. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
    Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
    Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma.
    Monteagudo C; Ramos D; Pellín-Carcelén A; Gil R; Callaghan RC; Martín JM; Alonso V; Murgui A; Navarro L; Calabuig S; López-Guerrero JA; Jordá E; Pellín A
    Clin Exp Metastasis; 2012 Aug; 29(6):625-37. PubMed ID: 22526457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
    Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
    J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
    Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
    Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
    Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL12/CXCR4 axis gene variants contribute to an increased vulnerability to HPV infection and cervical oncogenesis.
    Okuyama NCM; Cezar-Dos-Santos F; Trugilo KP; Esposito A; Guembarovski RL; Couto-Filho JD; Watanabe MAE; de Oliveira KB
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):793-802. PubMed ID: 35083551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CXCL12-3'A allele plays a favourable role in patients with multiple myeloma.
    Mazur G; Gębura K; Gieryng A; Butrym A; Wróbel T; Bogunia-Kubik K
    Cytokine; 2013 Oct; 64(1):422-6. PubMed ID: 23711392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells.
    Rubie C; Frick VO; Ghadjar P; Wagner M; Justinger C; Faust SK; Vicinus B; Gräber S; Kollmar O; Schilling MK
    J Transl Med; 2011 Feb; 9():22. PubMed ID: 21349176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
    Huang Y; Li DJ; Wang MY; Cheng HD
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.
    Cai C; Wang LH; Dong Q; Wu ZJ; Li MY; Sun YH
    Tissue Antigens; 2013 Sep; 82(3):165-70. PubMed ID: 24032722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCL12 and CXCR4 polymorphisms and expressions in peripheral blood from patients of hepatocellular carcinoma.
    Qin LF; Qin JM; Zhang JQ; Lv XP; Huang LY; Wang JJ
    Future Oncol; 2018 Jun; 14(13):1261-1271. PubMed ID: 29741398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan.
    Lin GT; Tseng HF; Yang CH; Hou MF; Chuang LY; Tai HT; Tai MH; Cheng YH; Wen CH; Liu CS; Huang CJ; Wang CL; Chang HW
    OMICS; 2009 Apr; 13(2):165-72. PubMed ID: 19196101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers.
    Yan M; Jene N; Byrne D; Millar EK; O'Toole SA; McNeil CM; Bates GJ; Harris AL; Banham AH; Sutherland RL; Fox SB
    Breast Cancer Res; 2011 Apr; 13(2):R47. PubMed ID: 21521526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility?
    Mitchell B; Leone D; Feller K; Menon S; Bondzie P; Yang S; Park HY; Mahalingam M
    Hum Pathol; 2014 Oct; 45(10):2094-100. PubMed ID: 25130395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCR4: A Potential Marker for Inflammatory Activity in Abdominal Aortic Aneurysm Wall.
    Tanios F; Pelisek J; Lutz B; Reutersberg B; Matevossian E; Schwamborn K; Hösel V; Eckstein HH; Reeps C
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):745-53. PubMed ID: 26346005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CXCL12, CXCR4 and CXCR7 expression in brain metastases.
    Salmaggi A; Maderna E; Calatozzolo C; Gaviani P; Canazza A; Milanesi I; Silvani A; DiMeco F; Carbone A; Pollo B
    Cancer Biol Ther; 2009 Sep; 8(17):1608-14. PubMed ID: 19625779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Polymorphism and Expression of CXCR4 in Breast Cancer.
    Okuyama Kishima M; Brajão de Oliveira K; Ariza CB; de Oliveira CE; Losi Guembarovski R; Banin Hirata BK; de Almeida FC; Vitiello GA; Trugilo KP; Guembarovski AF; Jorge Sobrinho W; Campos CZ; Watanabe MA
    Anal Cell Pathol (Amst); 2015; 2015():289510. PubMed ID: 26576337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CXCR4 and CXCL12 Expression in Rectal Tumors of Stage IV Patients Before and After Local Radiotherapy and Systemic Neoadjuvant Treatment.
    Tamas K; Domanska UM; van Dijk TH; Timmer-Bosscha H; Havenga K; Karrenbeld A; Sluiter WJ; Beukema JC; van Vugt MA; de Vries EG; Hospers GA; Walenkamp AM
    Curr Pharm Des; 2015; 21(17):2276-83. PubMed ID: 25557636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
    Zhang C; Cui GH; Liu F; Wu QL; Chen Y
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.